Presented
by

Presented by Oxford Global

Monthly Newsletter Sign-up

All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Video Content
Panel Discussion
Panel Discussion: Novel Drug Targets
Join Steve Rees, Pieter Fokko Van Loo, and Vivek Vishnudas for a discussion on novel drug targets.
08 November 2021
Target Based Discovery
Whitepaper
Inoviem - NPOT® technology for drug target identification
This whitepaper discusses the current classic methods of drug-target identification and how label-free Nematic Protein Organisation Technique (NPOT®) can secure, accelerate and improve the process of drug development.
26 October 2021
Target Based Discovery
Whitepaper
Reaction Biology - Drug Discovery Platform
This whitepaper details Reaction Biology's Drug Discovery Platform, covering Hit Identification, Hit to Lead, Lead Optimization, and more
25 October 2021
Target Based Discovery
Commentary
Covalent Inhibitors Discovery: Advancements and Developments
Covalent inhibitors have progressed significantly since they were discovered in the 18th century and are now experiencing a resurgence.
By Oliver Picken |
12 October 2021
Target Based Discovery
Video Content
Video Q&A
In Conversation... Phenotypic Discovery
Video Interview: Barbara Calamini, Principle Research Scientist, Eli Lilly & Company | Gregory Vladimer, Chief Scientific Officer, Allcyte | Iolanda Micco, Associate Director, Chemistry & Alliances, ViperGen
26 February 2021
Target Based Discovery
Video Content
Webinar
Application Of In Vitro And In Vivo Adme Pk Expl Tox Assays To Support Lead And Candidate Selections
Presented by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept
19 November 2020
Target Based Discovery
Written Q&A
Delivering Innovative Drug Discovery Starting Points
Torsten Hoffmann, Senior Vice President of Drug Discovery, Taros
02 January 2020
Target Based Discovery
Written Q&A
Finding the Right Target
Steve Rees, Vice-president Of Discovery Biology, Astrazeneca
02 January 2020
Target Based Discovery
Written Q&A
The Benefits of Using Allosteric and Orthosteric Antibodies
Martin Redhead, Group Leader Molecular Pharmacology, UCB
11 June 2019
Target Based Discovery
Written Q&A
Peptide Therapeutics in Drug Discovery
Alex Batchelor, CEO, Orbit Discovery
11 June 2019
Target Based Discovery

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Drug Discovery

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.